Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
J Alzheimers Dis. 2012;28(1):49-69. doi: 10.3233/JAD-2011-110977.
J Alzheimers Dis. 2012.
PMID: 21955818